
Novogenia
As one of the leading biotechnology companies in Europe, Novogenia has been providing fast, reliable and groundbreaking insights in the field of preventive and lifestyle genetic testing.
USD | 2022 |
---|---|
Revenues | 0000 |
EBITDA | 0000 |
Profit | 0000 |
EV | 0000 |
EV / revenue | 00.0x |
EV / EBITDA | 00.0x |
R&D budget | 0000 |
Source: Dealroom estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Novogenia
Edit
ACQUISITION by Rhodium Feb 2025